---
title: Catalent vs Syngene International
slug_a: catalent
slug_b: syngeneintl
site: cdmo
review_signal_gate: closed
canonical_path: /compare/catalent/syngeneintl
generated_by: BioBM Editorial AI
---

# Catalent vs Syngene International

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Catalent (catalent) is listed for cdmo. Leading global CDMO offering end-to-end development and manufacturing for pharma, biotech, and consumer health—spanning oral dose, biologics, cell and gene therapies, clinical supply, and specialty formulations with advanced technologies and worldwide GMP capacity.

Services: 30. Modalities: 6. Indications: 0. Locations: 9. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (30).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Syngene International (syngeneintl) is listed for both. Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

Services: 100. Modalities: 10. Indications: 14. Locations: 3. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (100).

Review summary: Review summary withheld until site-level review gate opens.